584
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Benign Clinical Course Following Atomoxetine Overdose

Page 57 | Published online: 07 Oct 2008

References

  • Product Information: Strattera(TM), Atomoxetine. Eli Lilly & Co.: Indianapolis, IN, 2002.
  • Witcher J W, Long A, Smith B, Sauer J M, Heilgenstein J, Wilens T, Spencer T, Biederman J. Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol Spring, 2003; 13(1):53–63.
  • Caballero J, Nahata M C. Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clin Ther Dec, 2003; 25(12):3065–3083.
  • Eiland L S, Guest A L. Atomoxetine treatment of attention-deficit/hyperactivity disorder. Ann Pharmacother Jan, 2004; 38(1):86–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.